Sasson Ravid, Luu Sang H, Thackray Varykina G, Mellon Pamela L
Department of Reproductive Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0674, USA.
Endocrinology. 2008 Jul;149(7):3643-55. doi: 10.1210/en.2007-1100. Epub 2008 Apr 10.
The human glycoprotein hormone alpha-subunit (alphaGSU) gene is transcriptionally regulated by glucocorticoids in a cell type-specific fashion. In direct contrast to repression of alphaGSU by glucocorticoids in placenta, glucocorticoid receptor (GR) modulation in the pituitary is little understood. We show that glucocorticoids stimulate the alphaGSU promoter in immortalized pituitary gonadotrope-derived LbetaT2 cells, whereas estrogens, androgens, and progestins have no significant effect. Moreover, GR acts in a dose-dependent manner at physiological concentrations of glucocorticoids. Transient transfection of GR with dexamethasone (Dex) treatment further stimulates the alphaGSU promoter, but this induction is severely diminished using a receptor mutated in the DNA-binding domain. Truncation and cis mutations demonstrate that glucocorticoid response element 2 (GRE2) and cAMP-response element 2 (CRE2) within -168 bp of the human alphaGSU promoter are critical for induction. Moreover, dominant-negative CRE-binding protein markedly inhibits basal but also Dex induction of alphaGSU promoter activity. Additionally, GR specifically binds to GRE2 in the human alphaGSU promoter in vitro and to the 5' region of the endogenous mouse alphaGSU gene in vivo. Furthermore, overexpression of the homeobox factor, Distal-less 3 that regulates this gene in placental cells through a site partially overlapping GRE2, blocks Dex induction of alphaGSU in gonadotrope cells, indicating that placenta-specific expression of Dlx3 may interfere with GR, resulting in repression in placental cells vs. induction in gonadotrope cells. These results demonstrate the stimulatory role played by glucocorticoids in alphaGSU gene expression in the pituitary gonadotrope, in contrast to repression in placental cells, and highlight the tissue-specific nature of steroid hormone action.
人糖蛋白激素α亚基(αGSU)基因受糖皮质激素以细胞类型特异性方式进行转录调控。与糖皮质激素在胎盘中对αGSU的抑制作用形成直接对比的是,糖皮质激素受体(GR)在垂体中的调节作用鲜为人知。我们发现,糖皮质激素可刺激永生化垂体促性腺激素来源的LβT2细胞中的αGSU启动子,而雌激素、雄激素和孕激素则无显著影响。此外,GR在糖皮质激素的生理浓度下呈剂量依赖性发挥作用。用糖皮质激素地塞米松(Dex)处理后瞬时转染GR可进一步刺激αGSU启动子,但使用在DNA结合域发生突变的受体时,这种诱导作用会严重减弱。截短和顺式突变表明,人αGSU启动子-168 bp内的糖皮质激素反应元件2(GRE2)和cAMP反应元件2(CRE2)对诱导作用至关重要。此外,显性负性CRE结合蛋白显著抑制αGSU启动子活性的基础水平以及Dex诱导作用。另外,GR在体外可特异性结合人αGSU启动子中的GRE2,在体内可结合内源性小鼠αGSU基因的5'区域。此外,同源盒因子Distal-less 3在胎盘细胞中通过与GRE2部分重叠的位点调节该基因,其过表达可阻断促性腺激素细胞中Dex对αGSU的诱导作用,这表明Dlx3在胎盘细胞中的特异性表达可能会干扰GR,导致其在胎盘细胞中发挥抑制作用,而在促性腺激素细胞中发挥诱导作用。这些结果证明了糖皮质激素在垂体促性腺激素细胞中对αGSU基因表达的刺激作用,与在胎盘细胞中的抑制作用形成对比,并突出了类固醇激素作用的组织特异性。